Learning to play guitar as a young boy growing up in Michigan, Billy Strings never saw it as a viable career path. Instead, he assumed he’d eventually “wither away in prison” or end up a drug addict.

It's rare these days for an artist to ask for fewer microphones, but after warming up in our space, Billy Strings did just that. Surrounded by his band, the bluegrass virtuoso brings back the spirit ...

Chris Wedel is a fan of all things tech and gadgets. Living in rural Kansas with his wife and two young boys makes finding ways to stay online tricky — not to mention making my homestead smarter.

The average one-year price target for Replimune Group (NasdaqGS:REPL) has been revised to $12.82 / share. This is an increase of 10.52% from the prior estimate of $11.60 dated November 14, 2025. The ...

Strings will be performing at the Fishers Event Center on Friday, April 24 and Saturday, April 25, 2026. The tour extension is in support of his latest full-length album, "Highway Prayers, which was ...

Britta DeVore is a Senior Author for Collider who has been known to dabble with Reality News as well. When she isn't sitting behind her laptop bringing readers her hot takes on upcoming projects or ...

Billy Strings never really stops touring, so the fact that he visited The Late Show With Stephen Colbert Thursday night was no surprise. I was a little bit surprised to see he was there to promote ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Gizmodo may earn an affiliate commission. Reading time 7 minutes ...

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...

NEW YORK, Sept. 15, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Replimune Group, Inc. (NASDAQ: REPL). Shareholders who purchased shares of REPL during ...

LOS ANGELES--(BUSINESS WIRE)--The DJS Law Group reminds investors of a class action lawsuit against Replimune Group, Inc. (“Replimune” or “the Company”) (NASDAQ: REPL) violations of §§10(b) and 20(a) ...

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, 2024 and July 21, 2025, both dates inclusive (the ...